These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 37737824)

  • 1. Chemical Synthesis of Microtubule-Associated Protein Tau.
    Powell WC; Jing R; Walczak MA
    J Am Chem Soc; 2023 Oct; 145(39):21514-21526. PubMed ID: 37737824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tau Interacting Proteins: Gaining Insight into the Roles of Tau in Health and Disease.
    Stancu IC; Ferraiolo M; Terwel D; Dewachter I
    Adv Exp Med Biol; 2019; 1184():145-166. PubMed ID: 32096036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Role of Tau Proteoforms in Health and Disease.
    Waheed Z; Choudhary J; Jatala FH; Fatimah ; Noor A; Zerr I; Zafar S
    Mol Neurobiol; 2023 Sep; 60(9):5155-5166. PubMed ID: 37266762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new non-aggregative splicing isoform of human Tau is decreased in Alzheimer's disease.
    García-Escudero V; Ruiz-Gabarre D; Gargini R; Pérez M; García E; Cuadros R; Hernández IH; Cabrera JR; García-Escudero R; Lucas JJ; Hernández F; Ávila J
    Acta Neuropathol; 2021 Jul; 142(1):159-177. PubMed ID: 33934221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tauopathies.
    Hernández F; Avila J
    Cell Mol Life Sci; 2007 Sep; 64(17):2219-33. PubMed ID: 17604998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative analysis of tau isoform transcripts in sporadic tauopathies.
    Connell JW; Rodriguez-Martin T; Gibb GM; Kahn NM; Grierson AJ; Hanger DP; Revesz T; Lantos PL; Anderton BH; Gallo JM
    Brain Res Mol Brain Res; 2005 Jun; 137(1-2):104-9. PubMed ID: 15950767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific post-translational modifications of soluble tau protein distinguishes Alzheimer's disease and primary tauopathies.
    Kyalu Ngoie Zola N; Balty C; Pyr Dit Ruys S; Vanparys AAT; Huyghe NDG; Herinckx G; Johanns M; Boyer E; Kienlen-Campard P; Rider MH; Vertommen D; Hanseeuw BJ
    Nat Commun; 2023 Jun; 14(1):3706. PubMed ID: 37349319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tau Isoforms: Gaining Insight into
    Corsi A; Bombieri C; Valenti MT; Romanelli MG
    Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Posttranslational modifications of tau--role in human tauopathies and modeling in transgenic animals.
    Chen F; David D; Ferrari A; Götz J
    Curr Drug Targets; 2004 Aug; 5(6):503-15. PubMed ID: 15270197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tau Abnormalities and the Potential Therapy in Alzheimer's Disease.
    Almansoub HAMM; Tang H; Wu Y; Wang DQ; Mahaman YAR; Wei N; Almansob YAM; He W; Liu D
    J Alzheimers Dis; 2019; 67(1):13-33. PubMed ID: 30507581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of tau (MAPT) in frontotemporal dementia and related tauopathies.
    Rademakers R; Cruts M; van Broeckhoven C
    Hum Mutat; 2004 Oct; 24(4):277-95. PubMed ID: 15365985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post-translational modifications of tau protein in Alzheimer's disease.
    Gong CX; Liu F; Grundke-Iqbal I; Iqbal K
    J Neural Transm (Vienna); 2005 Jun; 112(6):813-38. PubMed ID: 15517432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extensive deamidation at asparagine residue 279 accounts for weak immunoreactivity of tau with RD4 antibody in Alzheimer's disease brain.
    Dan A; Takahashi M; Masuda-Suzukake M; Kametani F; Nonaka T; Kondo H; Akiyama H; Arai T; Mann DM; Saito Y; Hatsuta H; Murayama S; Hasegawa M
    Acta Neuropathol Commun; 2013 Aug; 1():54. PubMed ID: 24252707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acetylated tau, a novel pathological signature in Alzheimer's disease and other tauopathies.
    Irwin DJ; Cohen TJ; Grossman M; Arnold SE; Xie SX; Lee VM; Trojanowski JQ
    Brain; 2012 Mar; 135(Pt 3):807-18. PubMed ID: 22366796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A current view on Tau protein phosphorylation in Alzheimer's disease.
    Wegmann S; Biernat J; Mandelkow E
    Curr Opin Neurobiol; 2021 Aug; 69():131-138. PubMed ID: 33892381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intrinsic Tau Acetylation Is Coupled to Auto-Proteolytic Tau Fragmentation.
    Cohen TJ; Constance BH; Hwang AW; James M; Yuan CX
    PLoS One; 2016; 11(7):e0158470. PubMed ID: 27383765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amyloidogenesis of Tau protein.
    Nizynski B; Dzwolak W; Nieznanski K
    Protein Sci; 2017 Nov; 26(11):2126-2150. PubMed ID: 28833749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Axodendritic sorting and pathological missorting of Tau are isoform-specific and determined by axon initial segment architecture.
    Zempel H; Dennissen FJA; Kumar Y; Luedtke J; Biernat J; Mandelkow EM; Mandelkow E
    J Biol Chem; 2017 Jul; 292(29):12192-12207. PubMed ID: 28536263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein Semisynthesis Provides Access to Tau Disease-Associated Post-translational Modifications (PTMs) and Paves the Way to Deciphering the Tau PTM Code in Health and Diseased States.
    Haj-Yahya M; Lashuel HA
    J Am Chem Soc; 2018 May; 140(21):6611-6621. PubMed ID: 29684271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.
    Šimić G; Babić Leko M; Wray S; Harrington C; Delalle I; Jovanov-Milošević N; Bažadona D; Buée L; de Silva R; Di Giovanni G; Wischik C; Hof PR
    Biomolecules; 2016 Jan; 6(1):6. PubMed ID: 26751493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.